PATENT CLAIM ANALYSIS

Application Number: 15750705
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "489000"]

Abstract:
The present invention relates to a composition comprising particles, wherein said particles comprise Poly(lactide-co-glycolide) polymer, therapeutically effective amount of liraglutide or a pharmaceutically acceptable salt thereof and a hydrophilic particle size modulating agent, wherein, the composition is free of added divalent metal ions. The composition provides effective blood glucose control for about 7 days when administered as once a week formulation to a period of about 30 days after single administration of a monthly dose to a patient in need thereof.

Claim (Index 13):
The composition of  claim 12 , wherein the total impurities of liraglutide is less than 3% as determined by HPLC.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.36364
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14087132', '11104877', '11826535', '10592769', '14783433']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7120862430716554
- 35 USC 102 Novelty (BERT): 0.4840763562860179
- Combined Prediction Score: 0.6892852543930916
- Mean Citation Score: 124.4594762
- Max Citation Score: 127.884285
- Similarity Product: 80.94201909632206

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test